{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T09:32:01Z","timestamp":1749547921260},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T00:00:00Z","timestamp":1482105600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s10822-016-9998-9","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T08:13:48Z","timestamp":1482135228000},"page":"267-273","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Computational chemistry at Janssen"],"prefix":"10.1007","volume":"31","author":[{"given":"Herman","family":"van Vlijmen","sequence":"first","affiliation":[]},{"given":"Renee L.","family":"Desjarlais","sequence":"additional","affiliation":[]},{"given":"Tara","family":"Mirzadegan","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,12,19]]},"reference":[{"key":"9998_CR1","unstructured":"2015 Global 2000: The World\u2019s Largest Drug And Biotech Companies (2015) Forbes. http:\/\/www.forbes.com\/sites\/liyanchen\/2015\/06\/04\/2015-global-2000-the-worlds-largest-drug-and-biotech-companies\/#5cd9e0cf5768 . Accessed 29 Oct 2016"},{"key":"9998_CR2","unstructured":"Taking Flight: Pharm Exec\u2019s Top 50 Pharma Companies (2015) PharmExec.com http:\/\/www.pharmexec.com\/taking-flight-pharm-execs-top-50-pharma-companies . Accessed 29 Oct 2016"},{"key":"9998_CR3","unstructured":"http:\/\/www.schrodinger.com\/ . Accessed 29 Oct 2016"},{"key":"9998_CR4","unstructured":"http:\/\/www.chemcomp.com\/ . Accessed 29 Oct 2016"},{"key":"9998_CR5","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1021\/ci200446y","volume":"51","author":"MD Hack","year":"2011","unstructured":"Hack MD, Rassokhin DN, Buyck C, Seierstad M, Skalkin A, ten Holte P, Jones TK, Mirzadegan T, Agrafiotis DK (2011) Library enhancement through the wisdom of crowds. J Chem Inf Model 51:3275\u20133286","journal-title":"J Chem Inf Model"},{"key":"9998_CR6","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.drudis.2015.01.002","volume":"20","author":"E Jacoby","year":"2015","unstructured":"Jacoby E, Tresadern G, Bembenek S, Wroblowski B, Buyck C, Neefs JM, Rassokhin D, Poncelet A, Hunt J, van Vlijmen H (2015) Extending kinome coverage by analysis of kinase inhibitor broad profiling data. Drug Discov Today 20:652\u2013658","journal-title":"Drug Discov Today"},{"issue":"D1","key":"9998_CR7","doi-asserted-by":"crossref","first-page":"D1220","DOI":"10.1093\/nar\/gkv1253","volume":"44","author":"G Papadatos","year":"2016","unstructured":"Papadatos G, Davies M, Dedman N, Chambers J, Gaulton A, Siddle J, Koks R, Irvine SA, Pettersson J, Goncharoff N, Hersey A, Overington JP (2016) SureChEMBL: A large-scale, chemically annotated patent document database. Nucleic Acids Res 44(D1):D1220\u2013D1228","journal-title":"Nucleic Acids Res"},{"key":"9998_CR8","unstructured":"Open PHACTS website. http:\/\/www.openphacts.org\/ . Accessed 29 Oct 2016"},{"key":"9998_CR9","unstructured":"Linked data, wikipedia. http:\/\/en.wikipedia.org\/wiki\/Linked_data . Accessed 29 Oct 2016"},{"key":"9998_CR10","doi-asserted-by":"crossref","first-page":"e115460","DOI":"10.1371\/journal.pone.0115460","volume":"9","author":"J Ratnam","year":"2014","unstructured":"Ratnam J, Zdrazil B, Digles D, Cuadrado-Rodriguez E, Neefs JM, Tipney H, Siebes R, Waagmeester A, Bradley G, Chau CH, Richter L, Brea J, Evelo CT, Jacoby E, Senger S, Loza MI, Ecker GF, Chichester C (2014) The application of the open pharmacological concepts triple store (Open PHACTS) to support drug discovery research. PLoS One 9:e115460","journal-title":"PLoS One"},{"key":"9998_CR11","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1021\/ci700267w","volume":"47","author":"DK Agrafiotis","year":"2007","unstructured":"Agrafiotis DK, Alex S, Dai H, Derkinderen A, Farnum M, Gates P, Izrailev S, Jaeger EP, Konstant P, Leung A, Lobanov VS, Marichal P, Martin D, Rassokhin DN, Shemanarev M, Skalkin A, Stong J, Tabruyn T, Vermeiren M, Wan J, Xu XY, Yao X (2007) Advanced biological and chemical discovery (ABCD): Centralizing discovery knowledge in an inherently decentralized world. J Chem Inf Model 47:1999\u20132014","journal-title":"J Chem Inf Model"},{"key":"9998_CR12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/nar\/gkt1031","volume":"42","author":"AP Bento","year":"2014","unstructured":"Bento AP, Gaulton A, Hersey A, Bellis LJ, Chambers J, Davies M, Kr\u00fcger FA, Light Y, Mak L, McGlinchey S, Nowotka M, Papadatos G, Santos R, Overington JP (2014) The ChEMBL bioactivity database: An update. Nucleic Acids Res 42:1083\u20131090","journal-title":"Nucleic Acids Res"},{"key":"9998_CR13","doi-asserted-by":"crossref","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J (2006) DrugBank: A comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34:D668\u2013D672","journal-title":"Nucleic Acids Res"},{"key":"9998_CR14","unstructured":"GOSTAR database, GVK Biosciences Private Limited, Hyderabad India. http:\/\/www.gostardb.com . Accessed 29 Oct 2016"},{"key":"9998_CR15","unstructured":"http:\/\/thomsonreuters.com\/ . Accessed 29 Oct 2016"},{"key":"9998_CR16","unstructured":"Euretos corporate website. http:\/\/www.euretos.com\/ . Accessed 29 Oct 2016"},{"key":"9998_CR17","unstructured":"Simm J, Arany A, Zakeri P, Haber T, Wegner JK, Chupakhin V, Ceulemans H, Moreau Y (2015) Macau: Scalable Bayesian multi-relational factorization with side information using MCMC. arXiv:1509.04610v2 [stat.ML]. http:\/\/arxiv.org\/pdf\/1509.04610v2.pdf . Accessed 29 Oct 2016"},{"key":"9998_CR18","unstructured":"Unterthiner T, Mayr, A, Klambauer, G, Steijaert, M, Wegner, JK, Ceulemans, H, Hochreiter, S (2014) Deep learning as an opportunity in virtual screening. Advances in neural information processing systems, 27. http:\/\/www.bioinf.jku.at\/publications\/2014\/NIPS2014a.pdf . Accessed 29 Oct 2016"},{"key":"9998_CR19","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1021\/acs.jmedchem.5b01974","volume":"59","author":"KL Damm-Ganamet","year":"2016","unstructured":"Damm-Ganamet KL, Bembenek SD, Venable JW, Castro GG, Mangelschots L, Peeters DC, Mcallister HM, Edwards JP, Disepio D, Mirzadegan T (2016) A prospective virtual screening study: Enriching hit rates and designing focus libraries to find inhibitors of PI3K\u03b4 and PI3K\u03b3. J Med Chem 59:4302\u20134313","journal-title":"J Med Chem"},{"key":"9998_CR20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ddtec.2004.11.004","volume":"1","author":"T Kuppens","year":"2004","unstructured":"Kuppens T, Bultinck P, Langenaeker W (2004) Determination of absolute configuration via vibrational circular dichroism. Drug Discov Today Technol 1:269\u2013275","journal-title":"Drug Discov Today Technol"},{"key":"9998_CR21","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/ja512751q","volume":"137","author":"L Wang","year":"2015","unstructured":"Wang L, Wu Y, Deng Y, Kim B, Pierce L, Krilov G, Lupyan D, Robinson S, Dahlgren MK, Greenwood J, Romero DL, Masse C, Knight JL, Steinbrecher T, Beuming T, Damm W, Harder E, Sherman W, Brewer M, Wester R, Murcko M, Frye L, Farid R, Lin T, Mobley DL, Jorgensen WL, Berne BJ, Friesner RA, Abel R (2015) Accurate and reliable prediction of relative ligand binding potency in prospective drug discovery by way of a modern free-energy calculation protocol and force field. J Am Chem Soc 137:2695\u20132703","journal-title":"J Am Chem Soc"},{"key":"9998_CR22","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.jcim.6b00220","volume":"56","author":"M Ciordia","year":"2016","unstructured":"Ciordia M, P\u00e9rez-Benito L, Delgado F, Trabanco AA, Tresadern G (2016) Application of Free Energy Perturbation for the Design of BACE1 Inhibitors. J Chem Inf Model 56:1856\u20131871","journal-title":"J Chem Inf Model"},{"key":"9998_CR23","unstructured":"http:\/\/www.eyesopen.com . Accessed 29 Oct 2016"},{"key":"9998_CR24","unstructured":"http:\/\/accelrys.com\/products\/collaborative-science\/biovia-pipeline-pilot\/ . Accessed 29 Oct 2016"},{"key":"9998_CR25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1021\/ci8003094","volume":"49","author":"F Moriaud","year":"2009","unstructured":"Moriaud F, Doppelt-Azeroual O, Martin L, Oguievetskaia K, Koch K, Vorotyntsev A, Adcock SA, Delfaud F (2009) Computational fragment-based approach at PDB scale by protein local similarity. J Chem Inf Model 49:280\u2013294","journal-title":"J Chem Inf Model"},{"key":"9998_CR26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","volume":"45","author":"G Wolber","year":"2005","unstructured":"Wolber G, Langer T (2005) LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 45:160\u2013169","journal-title":"J Chem Inf Model"},{"key":"9998_CR27","volume-title":"AMBER 2016","author":"DA Case","year":"2016","unstructured":"Case DA, Betz RM, Botello-Smith W, Cerutti DS, Cheatham TE III, Darden TA, Duke RE, Giese TJ, Gohlke H, Goetz AW, Homeyer N, Izadi S, Janowski P, Kaus J, Kovalenko A, Lee TS, LeGrand S, Li P, Lin C, Luchko T, Luo R, Madej B, Mermelstein D, Merz KM, Monard G, Nguyen H, Nguyen HT, Omelyan I, Onufriev A, Roe DR, Roitberg A, Sagui C, Simmerling CL, Swails J, Walker RC, Wang J, Wolf RM, Wu X, Xiao L, York DM, Kollman PA (2016) AMBER 2016. University of California, San Francisco"},{"key":"9998_CR28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10822-006-9099-2","volume":"21","author":"K Boda","year":"2007","unstructured":"Boda K, Seidel T, Gasteiger J (2007) Structure and reaction based evaluation of synthetic accessibility. J Comput Aided Mol Des 21:311\u2013325","journal-title":"J Comput Aided Mol Des"},{"key":"9998_CR29","unstructured":"Proasis software, Desert Scientific, Norwest, Australia. http:\/\/www.desertsci.com\/ . Accessed 29 Oct 2016"},{"key":"9998_CR30","unstructured":"Kinase KnowledgeBase, Eidogen-Sertanty, Oceanside CA. http:\/\/www.eidogen-sertanty.com\/ . Accessed 29 Oct 2016"},{"key":"9998_CR31","unstructured":"StarDrop, Optibrium Ltd, Cambridge UK. http:\/\/www.optibrium.com\/stardrop\/ . Accessed 29 Oct 2016"},{"key":"9998_CR32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones G, Willett P, Glen RC, Leach AR, Taylor R (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727\u2013748","journal-title":"J Mol Biol"},{"key":"9998_CR33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0022-2836(02)01408-0","volume":"326","author":"M Hendlich","year":"2003","unstructured":"Hendlich M, Bergner A, G\u00fcnther J, Klebe G (2003) Relibase\u2014design and development of a database for comprehensive analysis of protein\u2013ligand interactions. J Mol Biol 326:607\u2013620","journal-title":"J Mol Biol"},{"key":"9998_CR34","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1021\/ci900264n","volume":"49","author":"J Kolpak","year":"2009","unstructured":"Kolpak J, Connolly PJ, Lobanov VS, Agrafiotis DK (2009) Enhanced SAR maps: Expanding the data rendering capabilities of a popular medicinal chemistry tool. J Chem Inf Model 49:2221\u20132230","journal-title":"J Chem Inf Model"},{"key":"9998_CR35","unstructured":"Schr\u00f6dinger web site news (2011) http:\/\/www.schrodinger.com\/news\/schrodinger-signs-research-collaboration . Accessed 29 Oct 2016"},{"key":"9998_CR36","unstructured":"Flanders innovation & entrepreneurship. http:\/\/www.vlaio.be\/english . Accessed 29 Oct 2016"},{"key":"9998_CR37","unstructured":"The innovative medicines initiative. http:\/\/www.imi.europa.eu\/ . Accessed 29 Oct 2016"},{"key":"9998_CR38","unstructured":"HORIZON 2020: The EU framework programme for research and innovation. http:\/\/ec.europa.eu\/programmes\/horizon2020\/ . Accessed 29 Oct 2016"},{"key":"9998_CR39","unstructured":"European Lead Factory. http:\/\/www.europeanleadfactory.eu . Accessed 29 Oct 2016"},{"key":"9998_CR40","unstructured":"Kinetics for drug discovery. http:\/\/www.k4dd.eu\/ . Accessed 29 Oct 2016"},{"key":"9998_CR41","unstructured":"Structural genomics consortium. http:\/\/www.thesgc.org\/ . Accessed 29 Oct 2016"},{"key":"9998_CR42","unstructured":"Phenomics discovery initiative. http:\/\/npsc.ac.uk\/pdi . Accessed 29 Oct 2016"},{"key":"9998_CR43","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.1016\/j.bmcl.2011.06.067","volume":"21","author":"X Zhang","year":"2011","unstructured":"Zhang X, Song F, Kuo GH, Xiang A, Gibbs AC, Abad MC, Sun W, Kuo LC, Sui Z (2011) Optimization of a pyrazole hit from FBDD into a novel series of indazoles as ketohexokinase inhibitors. Bioorg Med Chem Lett 21:4762\u20134767","journal-title":"Bioorg Med Chem Lett"},{"key":"9998_CR44","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-381274-2.00006-6","volume":"493","author":"RL Desjarlais","year":"2011","unstructured":"Desjarlais RL (2011) Using computational techniques in fragment-based drug discovery. Methods Enzymol 493:137\u2013155","journal-title":"Methods Enzymol"},{"key":"9998_CR45","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/j.bmcl.2016.05.001","volume":"26","author":"JM Keith","year":"2016","unstructured":"Keith JM, Tichenor MS, Apodaca RL, Xiao W, Jones WM, Seierstad M, Pierce JM, Palmer JA, Webb M, Karbarz MJ, Scott BP, Wilson SJ, Wennerholm ML, Rizzolio M, Rynberg R, Chaplan SR, Breitenbucher JG (2016) The SAR of brain penetration for a series of heteroaryl urea FAAH inhibitors. Bioorg Med Chem Lett 26:3109\u20133114","journal-title":"Bioorg Med Chem Lett"},{"key":"9998_CR46","doi-asserted-by":"crossref","first-page":"12724","DOI":"10.1074\/jbc.M116.725325","volume":"291","author":"JM Blevitt","year":"2016","unstructured":"Blevitt JM, Hack MD, Herman K, Chang L, Keith JM, Mirzadegan T, Rao NL, Lebsack AD, Milla ME (2016) A single amino acid difference between mouse and human 5-lipoxygenase activating protein (FLAP) explains the speciation and differential pharmacology of novel FLAP inhibitors. J Biol Chem 291:12724\u201312731","journal-title":"J Biol Chem"},{"key":"9998_CR47","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1021\/jm401396p","volume":"57","author":"MD Cummings","year":"2014","unstructured":"Cummings MD, Lin TI, Hu L, Tahri A, McGowan D, Amssoms K, Last S, Devogelaere B, Rouan MC, Vijgen L, Berke JM, Dehertogh P, Fransen E, Cleiren E, van der Helm L, Fanning G, Nyanguile O, Simmen K, Van Remoortere P, Raboisson P, Vendeville S (2014) Discovery and early development of TMC647055, a non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase. J Med Chem 57:1880\u20131892","journal-title":"J Med Chem"},{"key":"9998_CR48","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1021\/acs.biochem.5b01210","volume":"55","author":"R DesJarlais","year":"2016","unstructured":"DesJarlais R, Tummino PJ (2016) Role of histone-modifying enzymes and their complexes in regulation of chromatin biology. BioChemistry 55:1584\u20131599","journal-title":"BioChemistry"},{"key":"9998_CR49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nchembio.1982","volume":"12","author":"MB Battles","year":"2015","unstructured":"Battles MB, Langedijk JP, Furmanova-Hollenstein P, Chaiwatpongsakorn S, Costello HM, Kwanten L, Vranckx L, Vink P, Jaensch S, Jonckers TH, Koul A, Arnoult E, Peeples ME, Roymans D, McLellan JS (2015) Molecular mechanism of respiratory syncytial virus fusion inhibitors. Nat Chem Biol 12:87\u201393","journal-title":"Nat Chem Biol"},{"key":"9998_CR50","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1021\/acs.jmedchem.5b01101","volume":"58","author":"FJ Rombouts","year":"2015","unstructured":"Rombouts FJ, Tresadern G, Delgado O, Mart\u00ednez-Lamenca C, Van Gool M, Garc\u00eda-Molina A, Alonso de Diego SA, Oehlrich D, Prokopcova H, Alonso JM, Austin N, Borghys H, Van Brandt S, Surkyn M, De Cleyn M, Vos A, Alexander R, Macdonald G, Moechars D, Gijsen H, Trabanco AA (2015) 1,4-Oxazine \u03b2-secretase 1 (BACE1) inhibitors: From hit generation to orally bioavailable brain penetrant leads. J Med Chem 58:8216\u20138235","journal-title":"J Med Chem"},{"key":"9998_CR51","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1021\/acschembio.5b00555","volume":"10","author":"N Bosc","year":"2015","unstructured":"Bosc N, Wroblowski B, Aci-S\u00e8che S, Meyer C, Bonnet P (2015) A proteometric analysis of human kinome: Insight into discriminant conformation-dependent residues. ACS Chem Biol 10:2827\u20132840","journal-title":"ACS Chem Biol"},{"key":"9998_CR52","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/pst.1665","volume":"14","author":"A Alonso","year":"2015","unstructured":"Alonso A, Milanzi E, Molenberghs G, Buyck C, Bijnens L (2015) Impact of selection bias on the evaluation of clusters of chemical compounds in the drug discovery process. Pharm Stat 14:129\u2013138","journal-title":"Pharm Stat"},{"key":"9998_CR53","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1021\/acs.jmedchem.5b01507","volume":"59","author":"V Pande","year":"2016","unstructured":"Pande V (2016) Understanding the complexity of epigenetic target space. J Med Chem 59:1299\u20131307","journal-title":"J Med Chem"},{"key":"9998_CR54","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/ncomms4369","volume":"5","author":"A Koul","year":"2014","unstructured":"Koul A, Vranckx L, Dhar N, G\u00f6hlmann HW, \u00d6zdemir E, Neefs JM, Schulz M, Lu P, M\u00f8rtz E, McKinney JD, Andries K, Bald D (2014) Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism. Nat Commun 5:3369","journal-title":"Nat Commun"},{"key":"9998_CR55","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jmgm.2014.07.006","volume":"53","author":"G Tresadern","year":"2014","unstructured":"Tresadern G, Cid JM, Trabanco AA (2014) QSAR design of triazolopyridine mGlu2 receptor positive allosteric modulators. J Mol Graph Model 53:82\u201391","journal-title":"J Mol Graph Model"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-016-9998-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-016-9998-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-016-9998-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:14:38Z","timestamp":1498356878000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-016-9998-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,19]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["9998"],"URL":"https:\/\/doi.org\/10.1007\/s10822-016-9998-9","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,19]]}}}